Method of treating neurological conditions with cardiac glycosides

Details for Australian Patent Application No. 2011203933 (hide)

Owner Phoenix Biotechnology, Inc.

Inventors Addington, Otis C.; Newman, Robert A.

Agent Watermark

Pub. Number AU-A-2011203933

PCT Pub. Number WO2011/085307

Priority 61/293,812 11.01.10 US

Filing date 10 January 2011

Wipo publication date 14 July 2011

International Classifications

A01N 45/00 Biocides, pest repellants or attractants, or plant growth regulators containing compounds having three or more carbocyclic rings condensed among themselves, at least one ring not being a six-membered ring

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/085307 Priority application(s): WO2011/085307

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203935-Azeotropic and azeotrope-like compositions of Z-1,1,1,4,4,4-hexafluoro-2-butene, trans-1,2-dichloroethylene, and 1,1,1,3,3-pentafluorobutane

2011203927-Biomatrices to attract and retain regenerative and reparative cells